Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH is the study of drugs and their interactions with the body.

A drug is defined as a substance which can be taken by Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH , injected into a Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS MUSCLE SODIUM PHARMACOLOGY LIDOCAINE MOUTH , Select one MORPHINE FIVE PREVENT MUSCLE ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH , or cavity of the body. As well as Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH via the lungs and applied Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH onto the skin. In order for a drug to be approved by the Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH it must be proven to Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH , Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH , or Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH a disease or condition.

Drug sources are placed into Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH categories. Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH which includes Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH to treat bradycardias and organophosphate overdoses as well as the drug Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH which is used as an analgesic. Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH drug source includes insulin, epinephrine (adrenaline), hormones, and blood clotting factors. Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH include the most abundant intracellular cation Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH and the most common extracellular cation Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH . Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH includes penicillin discovered in 1928 and other immunizations. Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH sources are made in a laboratory which include Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH which is used to treat V-fib and PVC's and the drug Select one MORPHINE FIVE PREVENT ANIMAL PLANT POTASSIUM ATROPINE FDA INHALED BLOOD VESSEL MICROORGANISMS CURE MINERALS SYNTHETIC VERSED TOPICALLY DIAGNOSIS SODIUM PHARMACOLOGY LIDOCAINE MOUTH which puts you to sleep in the operating room.

There are Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC categories of drug names. The Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC is the most detailed description of the drug and states the molecular structure along with chemical composition. The Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC name is nonproprietary name. Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC name is assigned to foster brand loyalty amount its customers or is a catchy name to allow customers to remember it or associate with it. The Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC name is the acknowledge name by the FDA and listed with the letters Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC which stands for the United States Pharmacopeia.

Two main books in which a paramedic student should understand. The Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC is a published book which lists drugs, drug source, compounds and interactions. A Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC is a publication which suggests to doctors how to use the drug.

History of drug oversight.

The Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC focused on mislabeling and establishing the USP listings as well as protecting the public from adulterated drugs. The Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC (names after Lavern and ?) prohibited false therapeutic claims in advertising and labeling. In 1914 Indiana Jones was popular in the Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC which banned opiates and cocaine in the United States for non-medical use. The FDA was created in 1938 under the Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC which gives regulatory oversight to new drugs and testing to ensure safety. In 1952 the Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC placed drugs into two categories; over the counter and prescription. In 1962 the Kefauver Harris Amendment required drug manufacturers to list side affects which is why a commercials list a disclaimer about possible reactions. In Comprehensive Drug Abuse Prevention and Control Act also know as the Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC of 1970 placed addictive drugs into Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC categories or Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC . Schedule I is highly abusive and has Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC approved medical use. Examples of Schedule I are heroin, marijuana, LSD. Schedule II is highly additive but has approved medical use. Examples of Schedule II are Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC , demoral and other pain killers. Schedule III are abusive but not as addictive. Examples of Schedule III are Lortab, Tussionex, and hydrocodone with Tylenol. Schedule IV drugs are your tranquilizers which includes valium and other Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC . Schedule V would include cough medication with small amounts of codeine or opium. In 1973 the Select one CONTROLLED SUBSTANCE ACT benzodiazepines FIVE OFFICIAL MORPHINE FEDERAL FOOD, DRUG, AND COSMETICS ACT UNITED STATES PHARMACOPEIA CHEMICAL NAME PURE FOOD AND DRUG ACT OF 1906 HARRISON NARCOTIC ACT SHIRLEY AMENDMENT OF 1912 TRADE PHYSICIAN'S DESK REFERENCE USP DURHAM-HUMPHREY AMENDMENT SCHEDULES NO DRUG ENFORCEMENT AGENCY FOUR GENERIC was created to enforce drug laws.

General Properties of Drugs

Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC   effects describes what the drug will do. The drug Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC explains how it causes the effects in the body. Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC effects are untoward effects that come with the drug. Example is that Benadryl makes you tired. An adverse reaction to an untoward effect is categorized as being Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC to it which may include systemic hives and difficulty breathing. Dose has many meanings; the Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC dose is to total amount which may be given. The Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC dose is the amount to be given per dose. Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC is when to use the drug and has two categories; Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC label which is what the drug has been studied and approved for and Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC label which includes uses not involved in the study. Contraindicated means when not to use it. There are two categories; Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC contraindications are when giving the drug is a case by case decision related to positive versus negative risks. Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC contraindication is when you absolutely do not give it. For example the absolute contraindication for Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC is 90 mmHg and the relative contraindication is 100 mmHg.

Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC is how the body handles a drug over a period of time. This includes Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC phases; Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC , Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC , Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC , and Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC . Pharmacokinetics is most commonly affected by pH levels, drug Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC , and Select one ABSOLUTE NITRO ABSORPTION CONCENTRATION INDICATION FOUR EXCRETION MAXIMUM PHARMACOKINETICS OFF RELATIVE SIDE ON ACTION BIOTRANSFORMATION BLOOD SINGLE THERAPUTIC DISTRIBUTION ALLERGIC flow.

Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL routes of absorption are through the Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL path. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL routes of absorption are through sites outside the Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL track. Most drug absorption in the enteral route takes place in the Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL .

Intravenous (IV) injection is the Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL and most reliably route of administration since it is totally not affected by first bypass. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL which stands for "by mouth" is the Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL route and takes about 20-30 minutes for most pills to start to work but substances like glucose, Tylenol and alcohol absorb much faster. Sublingual is considered a enteral route since absorption takes place through the mucus membranes of the sublingual tissue. Most sublingual drugs are Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL related. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL injection is when the needle enters the body at a 90 degree angle to the skin and administered into the middle of the muscle which allows for up to 2 mL (small muscles) to Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL mL (larger muscles) to be given. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL injection is when the needle is placed at a 45 degree angle to the skin and typically does not exceed Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL mL. SubQ is slower absorption than IM. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL is just as fast as IV and is given into the Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL marrow. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL is when drugs are absorbed through the skin. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL is the second fastest route of absorption. Select one SUBCUTANEOUS SMALL INSTESTINE ONE INHALATION PR INTRAMUSCULAR FIVE CARDIAC PO TRANSCUTANEOUS PARENTERAL BONE FASTEST ORAL INTRAOSSEOUSE GASTROINTESTINAL ENTERAL stands for "per rectum" and is affected by contents as well as 50% first by-pass.

Drug forms

Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS are compressed powders like Nitro and Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS . Capsules are used to hide Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS or protect the drug from high pH levels. An IV bag of 0.9% Sodium Chloride is termed a Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS since it is a mixture of one or more substances. A Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS is a mixture of particle distributed throughout a liquid by shaking; examples are MDI albuterol and charcoal. Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS is a miniature spray container used to direct drugs through the mouth into the lungs. Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS drugs are meant to stay on the top of the skin like Neosporin and sun lotions. Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS drugs are designed to be absorbed into circulation through the skin like birth control patches and motion sickness patches. Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS is via inhalation which include O2 and laughing gas known as Select one GLUCOSE NITRONOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS . A Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS is a solid material like vitamins or antibiotics that are cut/molded into a manageable size to swallow.

Drugs accumulate are storage sites by binding to specific tissues. Two types of drug reservoirs are; Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS protein binding and tissue binding in the Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS and Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS . For example Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS is an antibiotic which stores in the teeth and turned them yellow. The term Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS drugs are those drugs circulating and available to be active. When the amount of free drugs decrease the drug reservoirs release their drugs into circulation. The Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS barrier lines the CNS which allow Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS , Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS , Select one GLUCOSE NITRANOX BLOOD-BRAIN GAS TRANSCUTANEOUS FAT BENZODIAZEPINES PILL SOLUTION TOPICAL MDI OXYGEN FREE TETRACYCLINE TASTE SUSPENSION PLASMA BONES ASA TABLETS (valium), and anesthetics to pass but keeps out antibiotics and infection.

Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION is a process by which the drug is chemically converted to a Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION meaning broken down. Biotransformation can break a substance down for elimination or can activate the substance to make it active or potent. This usually takes place in the Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION but can also happen in the lungs and other organs.

Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION is the elimination of toxic or inactive metabolites which primarily takes place in the Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION but can also be accomplished in the intestines, lungs, sweat glands, mammary glands. Nothing can replace the kidneys to maintain homeostasis within the body. For those who have renal failure dialysis is needed. Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION is the excretion by artificial process through a machine which requires numerous treatments throughout the week. Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION dialysis uses the peritoneal membrane which surrounds the GI abdominal cavity. This way is less effective than hemodialysis.

Factors that influence actions of drugs are; Select one KIDNEYS PERITONEAL AGE LIVER EXCRETION METABOLITE HEMODIALYSIS BIOTRANSFORMATION , body mass (weight), and temperature along with many others.

Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC   is the study of how a drug acts on a living organism. Some terms to know are; Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC which causes a reaction, Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC which blocks an action, Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC which stimulates a reaction and Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC which blocks a reaction.

Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC range is the concentration that provides the highest probability of response. Biological Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC is the time needed to metabolize or eliminate half of the total amount of drug in the body. A drug is considered gone from the body after Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC half-lives. Therapeutic Select one INDEX POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC measures safety of a drug. The minimum levels are determined when 50% of lab animals demonstrate effects of the drugs. The lethal dose is determined when 50% of lab animals die.

Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC is when two or more agents/drugs working together to produce a result not obtained by and on agent independently. Select one POTENTIATION INDEX THERAPEUTIC FIVE ANTAGONIST SYNERGISM -MIMETIC HALF-LIFE ANGONIST PHARMACODYNAMICS -LYTIC is when one drug makes another drug more effective.

The following is not on exam 2. See if you can figure it out. By the end of the course you should get it.
Also class/categories of drugs are listed in detail at the end of the pharmacology outline.

Highlighted GREEN = medic must know
Highlighted YELLOW = medic should know
Highlighted RED = wouldn't hurt a medic to know